glp-1 lasker awardee Svetlana Mojsov describes a yearlong journey out of obscurity | Science GLP-1 Supplement 15-in-1 Complex,GLP1 for

coli levels in mice

The GLP-1 market will bifurcate into a branded premium injectable tier for highest-efficacy patients and an oral generic access tier for cost-sensitive patients growing total prescription volumes while compressing per-unit average selling prices from 2030 onward

Keeping GLP-1's off-plan avoids the challenge of manufacturer dictated limits on prior authorizations and step therapy - a true danger point for plans wanting the benefits of these drugs with appropriate guard rails to ensure they are used appropriately

March 2022 saw gallbladder disease added to labels, September 2023 brought ileus warnings, and November 2024 added pulmonary aspiration risks each update coming only after patients suffered these exact injuries

This occurs because GLP-1 medications deliberately slow how quickly your stomach processes food, which can increase pressure and acid exposure in the esophagus

In fact, death by any cause was 13% lower among patients treated with GLP-1 receptor agonists